Ismail Sergin1, Trent D Evans, Babak Razani. 1. aCardiovascular Division, Department of Medicine bDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA.
Abstract
PURPOSE OF REVIEW: The ability of macrophage lysosomes to degrade both exogenous and internally derived cargo is paramount to handling the overabundance of lipid and cytotoxic material present in the atherosclerotic plaque. We will discuss recent insights in both classical and novel functions of the lysosomal apparatus, as it pertains to the pathophysiology of atherosclerosis. RECENT FINDINGS: Lipid-mediated dysfunction in macrophage lysosomes appears to be a critical event in plaque progression. Consequences include enhanced inflammatory signalling [particularly the inflammasome/interleukin-1β axis] and an inability to interface with autophagy leading to a proatherogenic accumulation of dysfunctional organelles and protein aggregates. Aside from degradation, several novel functions have recently been ascribed to lysosomes, including involvement in macrophage polarization, generation of lipid signalling intermediates and serving as a nutrient depot for mechanistic target of rapamycin activation, each of which can have profound implications in atherosclerosis. Finally, the discovery of the transcription factor transcription factor EB as a mechanism of inducing lysosomal biogenesis can have therapeutic value by reversing lysosomal dysfunction in macrophages. SUMMARY: Lysosomes are a central organelle in the processing of exogenous and intracellular biomolecules. Together with recent data that implicate the degradation products of lysosomes in modulation of signalling pathways, these organelles truly do lay at a nexus in nutrient sensing and processing. Dissecting the full repertoire of lysosome function and ensuing dysfunction in plaque macrophages is pivotal to our understanding of atherogenesis.
PURPOSE OF REVIEW: The ability of macrophage lysosomes to degrade both exogenous and internally derived cargo is paramount to handling the overabundance of lipid and cytotoxic material present in the atherosclerotic plaque. We will discuss recent insights in both classical and novel functions of the lysosomal apparatus, as it pertains to the pathophysiology of atherosclerosis. RECENT FINDINGS:Lipid-mediated dysfunction in macrophage lysosomes appears to be a critical event in plaque progression. Consequences include enhanced inflammatory signalling [particularly the inflammasome/interleukin-1β axis] and an inability to interface with autophagy leading to a proatherogenic accumulation of dysfunctional organelles and protein aggregates. Aside from degradation, several novel functions have recently been ascribed to lysosomes, including involvement in macrophage polarization, generation of lipid signalling intermediates and serving as a nutrient depot for mechanistic target of rapamycin activation, each of which can have profound implications in atherosclerosis. Finally, the discovery of the transcription factor transcription factor EB as a mechanism of inducing lysosomal biogenesis can have therapeutic value by reversing lysosomal dysfunction in macrophages. SUMMARY: Lysosomes are a central organelle in the processing of exogenous and intracellular biomolecules. Together with recent data that implicate the degradation products of lysosomes in modulation of signalling pathways, these organelles truly do lay at a nexus in nutrient sensing and processing. Dissecting the full repertoire of lysosome function and ensuing dysfunction in plaque macrophages is pivotal to our understanding of atherogenesis.
Authors: Babak Razani; Chu Feng; Trey Coleman; Roy Emanuel; Haitao Wen; Seungmin Hwang; Jenny P Ting; Herbert W Virgin; Michael B Kastan; Clay F Semenkovich Journal: Cell Metab Date: 2012-03-20 Impact factor: 27.287
Authors: Andrew Folick; Holly D Oakley; Yong Yu; Eric H Armstrong; Manju Kumari; Lucas Sanor; David D Moore; Eric A Ortlund; Rudolf Zechner; Meng C Wang Journal: Science Date: 2015-01-02 Impact factor: 47.728
Authors: Stanley Ching-Cheng Huang; Bart Everts; Yulia Ivanova; David O'Sullivan; Marcia Nascimento; Amber M Smith; Wandy Beatty; Latisha Love-Gregory; Wing Y Lam; Christina M O'Neill; Cong Yan; Hong Du; Nada A Abumrad; Joseph F Urban; Maxim N Artyomov; Erika L Pearce; Edward J Pearce Journal: Nat Immunol Date: 2014-08-03 Impact factor: 25.606
Authors: Ilaria Zanoni; Johannes G Keller; Ursula G Sauer; Philipp Müller; Lan Ma-Hock; Keld A Jensen; Anna Luisa Costa; Wendel Wohlleben Journal: Chem Res Toxicol Date: 2022-05-20 Impact factor: 3.973
Authors: Nathalie Niyonzima; Jubayer Rahman; Natalia Kunz; Erin E West; Tilo Freiwald; Jigar V Desai; Nicolas S Merle; Alexandre Gidon; Bjørnar Sporsheim; Michail S Lionakis; Kristin Evensen; Beate Lindberg; Karolina Skagen; Mona Skjelland; Parul Singh; Markus Haug; Marieta M Ruseva; Martin Kolev; Jack Bibby; Olivia Marshall; Brett O'Brien; Nigel Deeks; Behdad Afzali; Richard J Clark; Trent M Woodruff; Milton Pryor; Zhi-Hong Yang; Alan T Remaley; Tom E Mollnes; Stephen M Hewitt; Bingyu Yan; Majid Kazemian; Máté G Kiss; Christoph J Binder; Bente Halvorsen; Terje Espevik; Claudia Kemper Journal: Sci Immunol Date: 2021-12-24
Authors: Ismail Sergin; Trent D Evans; Xiangyu Zhang; Somashubhra Bhattacharya; Carl J Stokes; Eric Song; Sahl Ali; Babak Dehestani; Karyn B Holloway; Paul S Micevych; Ali Javaheri; Jan R Crowley; Andrea Ballabio; Joel D Schilling; Slava Epelman; Conrad C Weihl; Abhinav Diwan; Daping Fan; Mohamed A Zayed; Babak Razani Journal: Nat Commun Date: 2017-06-07 Impact factor: 14.919